Metoprolol Succinate ER Alternatives Compared
| Metoprolol Succinate ER | Furosemide | Carvedilol |
|
|---|
| Metoprolol Succinate ER (metoprolol) | Furosemide | Carvedilol |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Metoprolol Succinate ER is a selective beta-blocker that is used to lower blood pressure or relieve symptoms of angina in people with heart disease. It may also be used in the treatment of certain... View more |
Prescription only
Furosemide significantly increases urination which relieves excess fluid, but its use may also lead to the depletion of certain electrolytes in the body (such as potassium). Prescribed for Edema... View more |
Prescription only
Carvedilol blocks both alpha and beta receptors to lower blood pressure and improve how the heart pumps blood. It is not usually recommended for people with pre-existing breathing problems... View more |
Related suggestions High Blood Pressure (Hypertension)
Heart Failure (Congestive Heart Failure)
|
|||||||||||||||||||||||
| More about (metoprolol) | More about Furosemide | More about Carvedilol | ||||||||||||||||||||||||
| Generic Status | ||||||||||||||||||||||||||
|
No lower-cost generic available |
||||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Metoprolol Succinate ER has an average rating of 5.9 out of 10 from a total of 73 ratings on Drugs.com. 45% of reviewers reported a positive effect, while 35% reported a negative effect. |
Furosemide has an average rating of 6.5 out of 10 from a total of 108 ratings on Drugs.com. 49% of reviewers reported a positive effect, while 24% reported a negative effect. |
Carvedilol has an average rating of 5.3 out of 10 from a total of 176 ratings on Drugs.com. 37% of reviewers reported a positive effect, while 45% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
See also: Metoprolol Succinate ER side effects in more detail. |
See also: furosemide side effects in more detail. |
Commonly reported side effects include:
See also: carvedilol side effects in more detail. |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Metoprolol Succinate ER prices |
View all furosemide prices |
View all carvedilol prices |
||||||||||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other metoprolol brands include: Kapspargo Sprinkle, Lopressor, Metoprolol Tartrate, Toprol-XL | Diaqua-2, Lasix | Coreg, Coreg CR | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
4 hours |
1.5 hours |
3.1 hours |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 492 drugs are known to interact with Metoprolol Succinate ER:
|
A total of 462 drugs are known to interact with furosemide:
|
A total of 520 drugs are known to interact with carvedilol:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
July 01, 1966 |
September 14, 1995 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.